Clinical Proteomics and Bioinformatics

Abdul R. Asif

Abdul R. Asif is professor of molecular medicine at the Institute of Clinical Chemistry, University Medical Center Göttingen (UMG). Beside this at the Central UMG-Laboratories, he is responsible for various diagnostic units for patient care. Prof. Asif has extensive experience in the field of clinical proteomics, in particular translational proteomics, differential proteomics, target elucidation and characterization of posttranslational modifications, preanalytics issues in clinical proteomics. His research focuses on identifying novel molecular targets of drugs, protein-protein and protein–drug interactions, ChIP-o-proteomics, immuno-proteomics for identification of new diagnostic and vaccine targets, use of proteomics tools and techniques to understand the physiology and pathophysiology of disease. His research group is collaborating with national and international partners in wide range of clinical and molecular medicine research topics. His teaching activities encompass a range of clinical proteomics, molecular medicine topics and investigative diagnostics. He has authored and co-authored more than 65 peer reviewed articles and a number of book contributions in the field of clinical proteomics and molecular medicine.

Viroj Wiwanitkit

Professor Viroj Wiwanitkit M.D is a Visiting University Professor, Hainan Medical University, Hainan China/Honorary professor, Dr DY Patil University, India/ Visiting Professor, Faculty of Medicine, University of Nis, Serbia/ Special Lecturer, Chulalongkorn University, Bangkok Thailand/ Adjunct Professor, Joesph Ayo Babalola University, Nigeria/ Professor, Senior Expert, Surin Rajabhat University, Surin, Thailand. He is presently a visiting University Professor, Hainan Medical University, China.

He holds degree M.D. (honour’s) Board of Family Medicine, Thai Medical Council, Fellowship of Clinical Scientist Association, USA (invited), Fellowship of International Society of Gene therapy and Molecular biology (invited), Fellowship of International Society of Cancer Therapy (invited), Membership of European Society of Pediatric Nutrition (invited),  Nominated by Marquis Who’s Who Records.

His Researches and publications have More than 2,000 publications in the international journal (in science and medicine index such as Scopus, PubMed, Medline, Chem Abstract and ISI). He also has more than 150 Invited chapters in many international textbooks and more than 30 textbooks in Thailand and International level.

Professor Viroj Wiwanitkit Main research interests include Tropical medicine, Laboratory science (biomedical), Nanoscience and nanotechnology, Bioinformatics and medical engineering, Family medicine, social medicine and public health.

Alexander E. Berezin

Professor Alexander E. Berezin received the MD degree from State Medical University, Zaporozhye, Ukraine, in 1992. PhD degree in field of Heart Failure was earned in State Medical University, Zaporozhye, Ukraine in 1994. The primary qualification is internal medicine; the secondary qualifications are cardiology, rheumatology, and ultrasound exam.

He is currently Professor of Medicine, Consultant of Cardiology Unit of Internal Medicine Department at State Medical University, Zaporozhye, Ukraine.

His research interest includes the fundamental study of biological markers of cardiovascular and metabolic diseases, heart failure, diabetes mellitus, obesity, endothelial dysfunction, microvesicles, stem cells, the implementation of visualization procedures and percutaneous cardiovascular interventions, the development of cardiovascular prevention and rehabilitation, especially in the field affected heart failure and coronary artery disease, improving knowledge in vascular biology and regenerative medicine.

Abdul R. Asif

Abdul R. Asif is professor of molecular medicine at the Institute of Clinical Chemistry, University Medical Center Göttingen (UMG). Beside this at the Central UMG-Laboratories, he is responsible for various diagnostic units for patient care. Prof. Asif has extensive experience in the field of clinical proteomics, in particular translational proteomics, differential proteomics, target elucidation and characterization of posttranslational modifications, preanalytics issues in clinical proteomics. His research focuses on identifying novel molecular targets of drugs, protein-protein and protein–drug interactions, ChIP-o-proteomics, immuno-proteomics for identification of new diagnostic and vaccine targets, use of proteomics tools and techniques to understand the physiology and pathophysiology of disease. His research group is collaborating with national and international partners in wide range of clinical and molecular medicine research topics. His teaching activities encompass a range of clinical proteomics, molecular medicine topics and investigative diagnostics. He has authored and co-authored more than 65 peer reviewed articles and a number of book contributions in the field of clinical proteomics and molecular medicine.

Viroj Wiwanitkit

Professor Viroj Wiwanitkit M.D is a Visiting University Professor, Hainan Medical University, Hainan China/Honorary professor, Dr DY Patil University, India/ Visiting Professor, Faculty of Medicine, University of Nis, Serbia/ Special Lecturer, Chulalongkorn University, Bangkok Thailand/ Adjunct Professor, Joesph Ayo Babalola University, Nigeria/ Professor, Senior Expert, Surin Rajabhat University, Surin, Thailand. He is presently a visiting University Professor, Hainan Medical University, China.

He holds degree M.D. (honour’s) Board of Family Medicine, Thai Medical Council, Fellowship of Clinical Scientist Association, USA (invited), Fellowship of International Society of Gene therapy and Molecular biology (invited), Fellowship of International Society of Cancer Therapy (invited), Membership of European Society of Pediatric Nutrition (invited),  Nominated by Marquis Who’s Who Records.

His Researches and publications have More than 2,000 publications in the international journal (in science and medicine index such as Scopus, PubMed, Medline, Chem Abstract and ISI). He also has more than 150 Invited chapters in many international textbooks and more than 30 textbooks in Thailand and International level.

Professor Viroj Wiwanitkit Main research interests include Tropical medicine, Laboratory science (biomedical), Nanoscience and nanotechnology, Bioinformatics and medical engineering, Family medicine, social medicine and public health.

Alexander E. Berezin

Professor Alexander E. Berezin received the MD degree from State Medical University, Zaporozhye, Ukraine, in 1992. PhD degree in field of Heart Failure was earned in State Medical University, Zaporozhye, Ukraine in 1994. The primary qualification is internal medicine; the secondary qualifications are cardiology, rheumatology, and ultrasound exam.

He is currently Professor of Medicine, Consultant of Cardiology Unit of Internal Medicine Department at State Medical University, Zaporozhye, Ukraine.

His research interest includes the fundamental study of biological markers of cardiovascular and metabolic diseases, heart failure, diabetes mellitus, obesity, endothelial dysfunction, microvesicles, stem cells, the implementation of visualization procedures and percutaneous cardiovascular interventions, the development of cardiovascular prevention and rehabilitation, especially in the field affected heart failure and coronary artery disease, improving knowledge in vascular biology and regenerative medicine.

Editorial Board.

In Press

Will be updated soon.

Current Issue

Volume 2, Issue 1

Clinical Proteomics and Bioinformatics is being discontinued as of 2018 and continued as Journal of Medicine and Therapeutics. We would like to express our sincere thanks to the authors, referees, and editors who contributed to the journal over past years.

Archive

External Databases & Indexes

Submit Manuscript

Clinical Proteomics and Bioinformatics (CPB) is now open for submissions. You can submit your manuscript to:  submissions@oatext.com

Publication Charges

Clinical Proteomics and Bioinformatics is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. This allows the scientific community to view, download, distribution of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License". In line with other open access journals we provide a flat fee submission structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). The process includes our maintenance, submission and peer review systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. We also have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable.

The publication charges for Clinical Proteomics and Bioinformatics are GBP 690.

Frequently Asked Questions (FAQs)

Why are your charges set at these levels?

All articles published in OA Text are open access. Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in OA Text Journals. The Article Publication Charges pay for the editorial and production costs of the journal, for hosting the website, publishing articles online, preparing HTML , PDF and XML versions of the articles and submitting the articles in electronic citation database like CrossRef.

Our financial goals are to:

• Recover capitalization costs;
• Produce sufficient revenue to allow for a sustainable and scalable publishing program, under continuous development;
• Bend the publication-charge cost downward over time.

Who will pay the APC?

Corresponding author or Co-authors has to make the payment on acceptance of the article.

When should I pay?

Corresponding author or the paying institutions should arrange for the payment once they are notified regarding acceptance of the article. APC is exempted for cases in which a wavier agreement has been made in-prior to submission.

*We request an immediate attention towards the payment as the articles will not be published unless the charges have been paid.

How do I pay?

Authors or institutions can make payments by two modes as per their convenience.

1. Wire/Bank transfer
2. Card payment

Note: No taxes are included in this charge, taxes will be applicable as per the policies of the country of the payee. Additional transaction charges may be levied on the author.

Can I be eligible for wavier on APC?

The waiver request will be considered on a case-by-case basis, and will be provided accordingly.

*The Waiver requests must be made during the submission process and will not be accepted after  processing of the manuscript.

Do I have to pay if my manuscript is rejected?

No, Article processing charges will not be applicable for articles rejected by the Editorial office.

Withdrawal Charges

Are reprints of my article included in the article processing charges (APCs)?

No, Article processing charges (APCs) do not include the charges for the reprints. Reprints facility is optional and should be order separately.